These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21159638)

  • 1. The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.
    van Deventer HW; Burgents JE; Wu QP; Woodford RM; Brickey WJ; Allen IC; McElvania-Tekippe E; Serody JS; Ting JP
    Cancer Res; 2010 Dec; 70(24):10161-9. PubMed ID: 21159638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
    Tengesdal IW; Menon DR; Osborne DG; Neff CP; Powers NE; Gamboni F; Mauro AG; D'Alessandro A; Stefanoni D; Henen MA; Mills TS; De Graaf DM; Azam T; Vogeli B; Palmer BE; Pietras EM; DeGregori J; Tan AC; Joosten LAB; Fujita M; Dinarello CA; Marchetti C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.
    Zhong H; Gutkin DW; Han B; Ma Y; Keskinov AA; Shurin MR; Shurin GV
    Int J Cancer; 2014 Jun; 134(11):2633-45. PubMed ID: 24443321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.
    Chow MT; Sceneay J; Paget C; Wong CS; Duret H; Tschopp J; Möller A; Smyth MJ
    Cancer Res; 2012 Nov; 72(22):5721-32. PubMed ID: 22986739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.
    Bruchard M; Mignot G; Derangère V; Chalmin F; Chevriaux A; Végran F; Boireau W; Simon B; Ryffel B; Connat JL; Kanellopoulos J; Martin F; Rébé C; Apetoh L; Ghiringhelli F
    Nat Med; 2013 Jan; 19(1):57-64. PubMed ID: 23202296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.
    Chen L; Huang CF; Li YC; Deng WW; Mao L; Wu L; Zhang WF; Zhang L; Sun ZJ
    Cell Mol Life Sci; 2018 Jun; 75(11):2045-2058. PubMed ID: 29184980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcγR mediates TLR2- and Syk-dependent NLRP3 inflammasome activation by inactivated Francisella tularensis LVS immune complexes.
    Duffy EB; Periasamy S; Hunt D; Drake JR; Harton JA
    J Leukoc Biol; 2016 Dec; 100(6):1335-1347. PubMed ID: 27365531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.
    Koehn BH; Saha A; McDonald-Hyman C; Loschi M; Thangavelu G; Ma L; Zaiken M; Dysthe J; Krepps W; Panthera J; Hippen K; Jameson SC; Miller JS; Cooper MA; Farady CJ; Iwawaki T; Ting JP; Serody JS; Murphy WJ; Hill GR; Murray PJ; Bronte V; Munn DH; Zeiser R; Blazar BR
    Blood; 2019 Nov; 134(19):1670-1682. PubMed ID: 31533918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
    Theivanthiran B; Evans KS; DeVito NC; Plebanek M; Sturdivant M; Wachsmuth LP; Salama AK; Kang Y; Hsu D; Balko JM; Johnson DB; Starr M; Nixon AB; Holtzhausen A; Hanks BA
    J Clin Invest; 2020 May; 130(5):2570-2586. PubMed ID: 32017708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism.
    Yao Y; Vent-Schmidt J; McGeough MD; Wong M; Hoffman HM; Steiner TS; Levings MK
    J Immunol; 2015 Jul; 195(2):488-97. PubMed ID: 26056255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation.
    Han C; Godfrey V; Liu Z; Han Y; Liu L; Peng H; Weichselbaum RR; Zaki H; Fu YX
    Sci Immunol; 2021 May; 6(59):. PubMed ID: 33963060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells.
    Savai R; Schermuly RT; Pullamsetti SS; Schneider M; Greschus S; Ghofrani HA; Traupe H; Grimminger F; Banat GA
    Cancer Res; 2007 Jun; 67(11):5443-53. PubMed ID: 17545626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression.
    Papafragkos I; Grigoriou M; Boon L; Kloetgen A; Hatzioannou A; Verginis P
    Front Immunol; 2022; 13():889075. PubMed ID: 36032139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the NLRP3 inflammasome by group B streptococci.
    Costa A; Gupta R; Signorino G; Malara A; Cardile F; Biondo C; Midiri A; Galbo R; Trieu-Cuot P; Papasergi S; Teti G; Henneke P; Mancuso G; Golenbock DT; Beninati C
    J Immunol; 2012 Feb; 188(4):1953-60. PubMed ID: 22250086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
    Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
    Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii.
    Gorfu G; Cirelli KM; Melo MB; Mayer-Barber K; Crown D; Koller BH; Masters S; Sher A; Leppla SH; Moayeri M; Saeij JP; Grigg ME
    mBio; 2014 Feb; 5(1):. PubMed ID: 24549849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells.
    Licandro G; Ling Khor H; Beretta O; Lai J; Derks H; Laudisi F; Conforti-Andreoni C; Liang Qian H; Teng GG; Ricciardi-Castagnoli P; Mortellaro A
    Eur J Immunol; 2013 Aug; 43(8):2126-37. PubMed ID: 23619996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1β mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer.
    Zhang Z; Chen Y; Pan X; Li P; Ren Z; Wang X; Chen Y; Shen S; Wang T; Lin A
    Cell Commun Signal; 2024 Aug; 22(1):408. PubMed ID: 39164774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection.
    Omosun Y; McKeithen D; Ryans K; Kibakaya C; Blas-Machado U; Li D; Singh R; Inoue K; Xiong ZG; Eko F; Black C; Igietseme J; He Q
    Infect Immun; 2015 Dec; 83(12):4662-72. PubMed ID: 26371131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.